Yi Fei Yang
Direttore/Membro del Consiglio presso RED PHASE INC.
Profilo
Yi Fei Yang currently works at China Tourism & Culture Investment Group Co., Ltd., as Independent Director from 2022, Red Phase, Inc., as Independent Director from 2021, and Xiamen Zeesan Biotech Co., Ltd., as Independent Director from 2021.
Posizioni attive di Yi Fei Yang
| Società | Posizione | Inizio |
|---|---|---|
| RED PHASE INC. | Direttore/Membro del Consiglio | 22/03/2021 |
| CHINA TOURISM AND CULTURE INVESTMENT GROUP CO.,LTD | Direttore/Membro del Consiglio | 20/12/2022 |
Xiamen Zeesan Biotech Co., Ltd.
 Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China. | Direttore/Membro del Consiglio | 23/08/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| RED PHASE INC. | Electronic Technology |
| CHINA TOURISM AND CULTURE INVESTMENT GROUP CO.,LTD | Commercial Services |
| Aziende private | 1 |
|---|---|
Xiamen Zeesan Biotech Co., Ltd.
Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China. | Health Services |
- Borsa valori
- Insiders
- Yi Fei Yang
